P1298: THE IRAK-4 INHIBITOR EMAVUSERTIB (CA-4948) FOR THE TREATMENT OF PRIMARY CNS LYMPHOMA by C. Von Roemeling, M. Iqbal, B. Doonan, L. Hoang-Minh, K. Klippel, H. Tun, D. Mitchell

Get full text

PB2096: A PHASE 1B/2 STUDY OF GB5121, A NOVEL, HIGHLY SELECTIVE, POTENT, AND CNS-PENETRANT BTK INHIBITOR FOR RELAPSED/REFRACTORY PRIMARY/SECONDARY CNS LYMPHOMA AND PRIMARY VITREORE... by C. Soussain, C. Grommes, R. Ward, C. Peterson, M. Cravets, A. Mathias, J. Sosa, B. Kirby, Z. Ding, I. Yusuf, M. Rose, M. Steinberg, H. Tun

Get full text

Prediction of odds for emergency cesarean section: A secondary analysis of the CHILD term birth cohort study. by Mon H Tun, Radha Chari, Padma Kaul, Fabiana V Mamede, Mike Paulden, Diana L Lefebvre, Stuart E Turvey, Theo J Moraes, Malcolm R Sears, Padmaja Subbarao, Piush J Mandhane

Get full text

Prediction of odds for emergency cesarean section: A secondary analysis of the CHILD term birth cohort study by Mon H. Tun, Radha Chari, Padma Kaul, Fabiana V. Mamede, Mike Paulden, Diana L. Lefebvre, Stuart E. Turvey, Theo J. Moraes, Malcolm R. Sears, Padmaja Subbarao, Piush J. Mandhane

Get full text

P1121: TAKEAIM LYMPHOMA- AN OPEN-LABEL, DOSE ESCALATION AND EXPANSION TRIAL OF EMAVUSERTIB (CA-4948) IN COMBINATION WITH IBRUTINIB IN PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOG... by E. Joffe, G. Nowakowski, H. Tun, A. Rosenthal, M. Lunning, R. Ramchandren, C.-C. Li, L. Zhou, E. Martinez, R. von Roemeling, R. Earhart, M. McMahon, I. Isufi, L. Leslie

Get full text